Sponsored byOpenSourceMed
Home / Guides / Spike Protein & Long COVID

Spike Protein and Long COVID: The Research Explained

Last updated: October 26, 2026

The correlation question

Long COVID (post-acute sequelae of SARS-CoV-2 infection, PASC) encompasses multi-system symptoms persisting months after acute illness. A parallel literature examines post-vaccination sequelae with overlapping symptom profiles. Swank et al. detected circulating spike mainly in people with Long COVID, up to 12 months after infection. Fehrer et al. found serum spike in a minority of people after infection but no association with post-COVID symptoms, so the evidence is mixed.

For how long spike is typically detectable, see how long spike protein stays in the body. For the parallel post-vaccination literature, see spike protein and post-vaccination syndrome.

Symptom clusters

  • Fatigue and post-exertional malaise
  • Brain fog / cognitive dysfunction
  • Cardiovascular (palpitations, myocarditis subsets)
  • Neuropathy and autonomic dysfunction
  • Dyspnea and exercise intolerance
Full symptoms evidence →

Proposed mechanistic overlap

Shared hypotheses include endothelial dysfunction, fibrin-resistant microclots (S1 subunit), neuroinflammation, immune dysregulation, and tissue antigen reservoirs. Spike may act as a sustained trigger in some individuals while others clear antigen without sequelae.

Pathological mechanisms →

NIH RECOVER & ongoing research

The NIH RECOVER Initiative and related trials (including SPEAR apheresis studies) are investigating biomarker-guided interventions. No spike-directed therapy is yet standard of care.

Therapeutics overview →